Shukra Pharmaceuticals Hits New 52-Week High of Rs. 37.97

Shukra Pharmaceuticals has reached a significant milestone by hitting a new 52-week high of Rs. 37.97 on October 20, 2025. This achievement underscores the stock's strong performance, particularly as it has outperformed its sector by 1.59% today. Over the past eight days, Shukra Pharmaceuticals has demonstrated consistent upward momentum, recording a remarkable 17.05% increase in returns during this period.
In terms of technical indicators, the stock is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a robust market position. The impressive one-year performance of Shukra Pharmaceuticals stands at 425.25%, significantly outpacing the Sensex, which has only gained 4.02% in the same timeframe.

This upward trend in Shukra Pharmaceuticals coincides with a broader market rally, as the Sensex has also reached a new 52-week high of 84,485.03, reflecting a bullish sentiment across the market. The overall performance of both the stock and the index highlights a positive environment for investors in the pharmaceuticals and biotechnology sector.